Rowlandmiller & PARTNERS.ADV Decreases Stake in Maximus, Inc. (NYSE:MMS)

Rowlandmiller & PARTNERS.ADV lessened its stake in shares of Maximus, Inc. (NYSE:MMS) by 7.3% during the 4th quarter, Holdings Channel reports. The fund owned 25,366 shares of the health services provider’s stock after selling 1,993 shares during the quarter. Rowlandmiller & PARTNERS.ADV’s holdings in Maximus were worth $1,894,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the stock. Wealthspire Advisors LLC raised its holdings in shares of Maximus by 21.1% during the 4th quarter. Wealthspire Advisors LLC now owns 26,682 shares of the health services provider’s stock worth $1,992,000 after acquiring an additional 4,657 shares during the period. Hudson Edge Investment Partners Inc. raised its holdings in shares of Maximus by 45.3% during the 4th quarter. Hudson Edge Investment Partners Inc. now owns 10,398 shares of the health services provider’s stock worth $776,000 after acquiring an additional 3,243 shares during the period. Van Berkom & Associates Inc. raised its holdings in shares of Maximus by 8.5% during the 4th quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider’s stock worth $93,792,000 after acquiring an additional 98,264 shares during the period. Handelsbanken Fonder AB raised its holdings in shares of Maximus by 14.1% during the 4th quarter. Handelsbanken Fonder AB now owns 15,416 shares of the health services provider’s stock worth $1,151,000 after acquiring an additional 1,900 shares during the period. Finally, Ieq Capital LLC purchased a new position in shares of Maximus during the 4th quarter worth $541,000. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Raymond James upgraded Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target on the stock in a report on Thursday, January 2nd. StockNews.com lowered Maximus from a “buy” rating to a “hold” rating in a report on Friday, February 14th.

Maximus Stock Down 1.2 %

Shares of NYSE:MMS opened at $65.95 on Monday. The business has a 50-day moving average price of $73.79 and a 200 day moving average price of $81.63. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. The company has a market capitalization of $3.73 billion, a price-to-earnings ratio of 14.18 and a beta of 0.72. Maximus, Inc. has a 12-month low of $64.53 and a 12-month high of $93.97.

Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Sell-side analysts expect that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Saturday, February 15th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.82%. The ex-dividend date of this dividend is Friday, February 14th. Maximus’s payout ratio is 25.81%.

Insider Buying and Selling

In other Maximus news, insider Michelle F. Link sold 2,208 shares of Maximus stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total value of $163,016.64. Following the completion of the transaction, the insider now directly owns 6,567 shares of the company’s stock, valued at $484,841.61. The trade was a 25.16 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Raymond B. Ruddy bought 3,490 shares of the company’s stock in a transaction on Thursday, December 12th. The stock was purchased at an average cost of $71.46 per share, with a total value of $249,395.40. Following the completion of the transaction, the director now owns 112,520 shares in the company, valued at $8,040,679.20. This represents a 3.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 7,063 shares of company stock valued at $502,017. 1.60% of the stock is currently owned by insiders.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.